Edition:
United Kingdom

People: Atara Biotherapeutics Inc (ATRA.OQ)

ATRA.OQ on NASDAQ Stock Exchange Global Select Market

31.86USD
18 Apr 2019
Change (% chg)

-- (--)
Prev Close
$31.86
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
168,819
52-wk High
$54.45
52-wk Low
$27.85

Soffer, Gad 

Mr. Gad Soffer serves as Executive Vice President and Chief Strategy Officer of the Company. From August 2008 to March 2013, he held various roles in Business Development and served as Global Project Leader Abraxane at Celgene. From August 2008 to March 2013, he held various roles in Business Development and served as Global Project Leader Abraxane at Celgene. From June 2000 to June 2001 and from April 2004 to April 2006, Mr. Soffer was a healthcare consultant with Easton Associates. He received an A.B. from Harvard University, an M.S. from Columbia University and an M.B.A. from Harvard Business School.

Basic Compensation

Total Annual Compensation, USD 490,121
Restricted Stock Award, USD 2,605,890
Long-Term Incentive Plans, USD --
All Other, USD 2,027
Fiscal Year Total, USD 3,098,040

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Isaac Ciechanover

3,366,820

Utpal Koppikar

--

Joseph Newell

1,641,820

Christopher Haqq

3,298,020

Mitchall Clark

1,402,910

Gad Soffer

3,098,040
As Of  31 Dec 2017